Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.

Clinical biochemistry - 1 Jan 2010

Wainstein Rodrigo V, Wainstein Marco V, Ribeiro Jorge P, Dornelles Laura V, Tozzati Paula, Ashton-Prolla Patrícia, Ewald Ingrid P, Vietta Giovana, Polanczyk Carisi A

Abstract excerpt

OBJECTIVES: Myeloperoxidase (MPO) polymorphism -463 has been related to higher cardiovascular risk. This study was conducted to test whether the MPO promoter polymorphism -463A/G and MPO plasma levels are associated with coronary artery disease (CAD) severity. DESIGN AND METHODS: Patients submitted to elective coronariography were enrolled, CAD severity was assessed and blood samples collected to identify the MPO...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Angiography
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Peroxidase

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Risk Factors

Share to Severity of Illness Index

Source

Identifiers

PMID: 19651119
DOI: 10.1016/j.clinbiochem.2009.07.022

Genes

MPO
CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.PMID 19651119Read ↗

The myeloperoxidase -463G/A polymorphism and coronary artery disease risk: A meta-analysis of 1938 cases and 1990 controls.Semantic proximity Read ↗

Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis.Semantic proximity Read ↗

Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis.Semantic proximity Read ↗

PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects.Semantic proximity Read ↗

Meta-analysis of myeloperoxidase gene polymorphism and coronary artery disease susceptibility.Semantic proximity Read ↗

Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease.Semantic proximity Read ↗

Myeloperoxidase polymorphism related to cardiovascular events in coronary artery diseaseSemantic proximity Read ↗

Plasma myeloperoxidase level and peripheral arterial disease.Semantic proximity Read ↗

Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?Semantic proximity Read ↗

Myeloperoxidase gene variation as a determinant of atherosclerosis progression in the abdominal and thoracic aorta: an autopsy study.Semantic proximity Read ↗

Genetic polymorphisms of myeloperoxidase and their effect on hypertension.Semantic proximity Read ↗

System study of MPO promoter high-frequency polymorphic variants on transcription factor network.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.